Logo image of CTVA

CORTEVA INC (CTVA) Stock Fundamental Analysis

NYSE:CTVA - New York Stock Exchange, Inc. - US22052L1044 - Common Stock - Currency: USD

68.96  -0.22 (-0.32%)

After market: 69.1 +0.14 (+0.2%)

Fundamental Rating

5

CTVA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. CTVA has an average financial health and profitability rating. CTVA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CTVA had positive earnings in the past year.
In the past year CTVA had a positive cash flow from operations.
In the past 5 years CTVA has always been profitable.
In the past 5 years CTVA always reported a positive cash flow from operatings.
CTVA Yearly Net Income VS EBIT VS OCF VS FCFCTVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

CTVA's Return On Assets of 2.71% is in line compared to the rest of the industry. CTVA outperforms 58.82% of its industry peers.
The Return On Equity of CTVA (4.69%) is comparable to the rest of the industry.
The Return On Invested Capital of CTVA (5.35%) is comparable to the rest of the industry.
CTVA had an Average Return On Invested Capital over the past 3 years of 4.97%. This is below the industry average of 7.01%.
The last Return On Invested Capital (5.35%) for CTVA is above the 3 year average (4.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.71%
ROE 4.69%
ROIC 5.35%
ROA(3y)2.21%
ROA(5y)2.47%
ROE(3y)3.76%
ROE(5y)4.19%
ROIC(3y)4.97%
ROIC(5y)3.98%
CTVA Yearly ROA, ROE, ROICCTVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6 -6

1.3 Margins

CTVA has a better Profit Margin (6.77%) than 74.12% of its industry peers.
CTVA's Profit Margin has declined in the last couple of years.
The Operating Margin of CTVA (13.22%) is better than 70.59% of its industry peers.
CTVA's Operating Margin has improved in the last couple of years.
CTVA has a better Gross Margin (44.63%) than 90.59% of its industry peers.
CTVA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.22%
PM (TTM) 6.77%
GM 44.63%
OM growth 3Y13.79%
OM growth 5Y24.06%
PM growth 3Y-21.84%
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y2.77%
CTVA Yearly Profit, Operating, Gross MarginsCTVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTVA is destroying value.
Compared to 1 year ago, CTVA has less shares outstanding
The number of shares outstanding for CTVA has been reduced compared to 5 years ago.
The debt/assets ratio for CTVA is higher compared to a year ago.
CTVA Yearly Shares OutstandingCTVA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CTVA Yearly Total Debt VS Total AssetsCTVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

An Altman-Z score of 2.33 indicates that CTVA is not a great score, but indicates only limited risk for bankruptcy at the moment.
CTVA has a better Altman-Z score (2.33) than 64.71% of its industry peers.
CTVA has a debt to FCF ratio of 1.94. This is a very positive value and a sign of high solvency as it would only need 1.94 years to pay back of all of its debts.
CTVA's Debt to FCF ratio of 1.94 is amongst the best of the industry. CTVA outperforms 90.59% of its industry peers.
CTVA has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
CTVA has a Debt to Equity ratio of 0.13. This is amongst the best in the industry. CTVA outperforms 84.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.94
Altman-Z 2.33
ROIC/WACC0.59
WACC9.09%
CTVA Yearly LT Debt VS Equity VS FCFCTVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

CTVA has a Current Ratio of 1.44. This is a normal value and indicates that CTVA is financially healthy and should not expect problems in meeting its short term obligations.
CTVA has a Current ratio of 1.44. This is in the lower half of the industry: CTVA underperforms 68.24% of its industry peers.
A Quick Ratio of 1.00 indicates that CTVA may have some problems paying its short term obligations.
CTVA has a Quick ratio of 1.00. This is comparable to the rest of the industry: CTVA outperforms 43.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1
CTVA Yearly Current Assets VS Current LiabilitesCTVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

4

3. Growth

3.1 Past

CTVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.77%, which is quite good.
CTVA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.18% yearly.
CTVA shows a decrease in Revenue. In the last year, the revenue decreased by -0.01%.
Measured over the past years, CTVA shows a small growth in Revenue. The Revenue has been growing by 4.08% on average per year.
EPS 1Y (TTM)15.77%
EPS 3Y6.18%
EPS 5YN/A
EPS Q2Q%26.97%
Revenue 1Y (TTM)-0.01%
Revenue growth 3Y2.6%
Revenue growth 5Y4.08%
Sales Q2Q%-1.67%

3.2 Future

The Earnings Per Share is expected to grow by 11.94% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.70% on average over the next years.
EPS Next Y19.35%
EPS Next 2Y18.12%
EPS Next 3Y16.95%
EPS Next 5Y11.94%
Revenue Next Year1.96%
Revenue Next 2Y2.75%
Revenue Next 3Y2.83%
Revenue Next 5Y2.7%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTVA Yearly Revenue VS EstimatesCTVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B
CTVA Yearly EPS VS EstimatesCTVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.72 indicates a rather expensive valuation of CTVA.
The rest of the industry has a similar Price/Earnings ratio as CTVA.
CTVA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.03.
A Price/Forward Earnings ratio of 19.38 indicates a rather expensive valuation of CTVA.
CTVA's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CTVA to the average of the S&P500 Index (21.94), we can say CTVA is valued inline with the index average.
Industry RankSector Rank
PE 24.72
Fwd PE 19.38
CTVA Price Earnings VS Forward Price EarningsCTVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTVA indicates a slightly more expensive valuation: CTVA is more expensive than 61.18% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CTVA is valued a bit cheaper than 63.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.41
EV/EBITDA 13.94
CTVA Per share dataCTVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

CTVA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CTVA may justify a higher PE ratio.
A more expensive valuation may be justified as CTVA's earnings are expected to grow with 16.95% in the coming years.
PEG (NY)1.28
PEG (5Y)N/A
EPS Next 2Y18.12%
EPS Next 3Y16.95%

4

5. Dividend

5.1 Amount

CTVA has a yearly dividend return of 1.00%, which is pretty low.
CTVA's Dividend Yield is comparable with the industry average which is at 3.70.
Compared to an average S&P500 Dividend Yield of 2.36, CTVA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1%

5.2 History

The dividend of CTVA is nicely growing with an annual growth rate of 30.66%!
CTVA has been paying a dividend for over 5 years, so it has already some track record.
CTVA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)30.66%
Div Incr Years5
Div Non Decr Years5
CTVA Yearly Dividends per shareCTVA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

40.53% of the earnings are spent on dividend by CTVA. This is a bit on the high side, but may be sustainable.
The dividend of CTVA is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP40.53%
EPS Next 2Y18.12%
EPS Next 3Y16.95%
CTVA Yearly Income VS Free CF VS DividendCTVA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
CTVA Dividend Payout.CTVA Dividend Payout, showing the Payout Ratio.CTVA Dividend Payout.PayoutRetained Earnings

CORTEVA INC

NYSE:CTVA (5/21/2025, 8:04:00 PM)

After market: 69.1 +0.14 (+0.2%)

68.96

-0.22 (-0.32%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners87.39%
Inst Owner Change0.34%
Ins Owners0.11%
Ins Owner Change3.49%
Market Cap47.10B
Analysts80
Price Target70.86 (2.76%)
Short Float %1.37%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield 1%
Yearly Dividend0.66
Dividend Growth(5Y)30.66%
DP40.53%
Div Incr Years5
Div Non Decr Years5
Ex-Date06-02 2025-06-02 (0.17)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.15%
Min EPS beat(2)0.21%
Max EPS beat(2)26.09%
EPS beat(4)3
Avg EPS beat(4)-7.72%
Min EPS beat(4)-61.17%
Max EPS beat(4)26.09%
EPS beat(8)6
Avg EPS beat(8)15.91%
EPS beat(12)10
Avg EPS beat(12)34.5%
EPS beat(16)13
Avg EPS beat(16)30.33%
Revenue beat(2)0
Avg Revenue beat(2)-3.7%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)-2.71%
Revenue beat(4)0
Avg Revenue beat(4)-6.39%
Min Revenue beat(4)-15.45%
Max Revenue beat(4)-2.71%
Revenue beat(8)1
Avg Revenue beat(8)-5.27%
Revenue beat(12)4
Avg Revenue beat(12)-3.08%
Revenue beat(16)7
Avg Revenue beat(16)-1.25%
PT rev (1m)0.03%
PT rev (3m)5.33%
EPS NQ rev (1m)-5.23%
EPS NQ rev (3m)-5.13%
EPS NY rev (1m)1.26%
EPS NY rev (3m)1.33%
Revenue NQ rev (1m)-0.59%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 24.72
Fwd PE 19.38
P/S 2.8
P/FCF 22.41
P/OCF 17.81
P/B 1.94
P/tB 9
EV/EBITDA 13.94
EPS(TTM)2.79
EY4.05%
EPS(NY)3.56
Fwd EY5.16%
FCF(TTM)3.08
FCFY4.46%
OCF(TTM)3.87
OCFY5.62%
SpS24.65
BVpS35.56
TBVpS7.66
PEG (NY)1.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 4.69%
ROCE 7.26%
ROIC 5.35%
ROICexc 5.71%
ROICexgc 15.65%
OM 13.22%
PM (TTM) 6.77%
GM 44.63%
FCFM 12.49%
ROA(3y)2.21%
ROA(5y)2.47%
ROE(3y)3.76%
ROE(5y)4.19%
ROIC(3y)4.97%
ROIC(5y)3.98%
ROICexc(3y)5.51%
ROICexc(5y)4.45%
ROICexgc(3y)17.68%
ROICexgc(5y)14.5%
ROCE(3y)6.47%
ROCE(5y)5.18%
ROICexcg growth 3Y17.34%
ROICexcg growth 5Y37%
ROICexc growth 3Y18.15%
ROICexc growth 5Y33.64%
OM growth 3Y13.79%
OM growth 5Y24.06%
PM growth 3Y-21.84%
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y2.77%
F-Score8
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.94
Debt/EBITDA 0.91
Cap/Depr 44.65%
Cap/Sales 3.23%
Interest Coverage 250
Cash Conversion 76.84%
Profit Quality 184.39%
Current Ratio 1.44
Quick Ratio 1
Altman-Z 2.33
F-Score8
WACC9.09%
ROIC/WACC0.59
Cap/Depr(3y)49.09%
Cap/Depr(5y)46.74%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.49%
Profit Quality(3y)117.89%
Profit Quality(5y)141.89%
High Growth Momentum
Growth
EPS 1Y (TTM)15.77%
EPS 3Y6.18%
EPS 5YN/A
EPS Q2Q%26.97%
EPS Next Y19.35%
EPS Next 2Y18.12%
EPS Next 3Y16.95%
EPS Next 5Y11.94%
Revenue 1Y (TTM)-0.01%
Revenue growth 3Y2.6%
Revenue growth 5Y4.08%
Sales Q2Q%-1.67%
Revenue Next Year1.96%
Revenue Next 2Y2.75%
Revenue Next 3Y2.83%
Revenue Next 5Y2.7%
EBIT growth 1Y17.41%
EBIT growth 3Y16.75%
EBIT growth 5Y29.12%
EBIT Next Year52.44%
EBIT Next 3Y21.04%
EBIT Next 5Y14.99%
FCF growth 1Y834.97%
FCF growth 3Y-10.43%
FCF growth 5YN/A
OCF growth 1Y808.94%
OCF growth 3Y-7.69%
OCF growth 5Y14.92%